Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$6.87 - $11.11 $789,672 - $1.28 Million
-114,945 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$7.7 - $37.13 $500,076 - $2.41 Million
64,945 Added 129.89%
114,945 $1.12 Million
Q3 2021

Nov 15, 2021

BUY
$26.46 - $37.15 $1.32 Million - $1.86 Million
50,000 New
50,000 $1.7 Million
Q4 2019

Feb 14, 2020

SELL
$31.7 - $69.93 $1.3 Million - $2.87 Million
-41,000 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$19.95 - $38.85 $817,950 - $1.59 Million
41,000 New
41,000 $1.39 Million
Q1 2018

May 14, 2018

SELL
$20.04 - $29.71 $1.37 Million - $2.02 Million
-68,154 Closed
0 $0
Q4 2017

Feb 14, 2018

SELL
$16.54 - $24.2 $30,532 - $44,673
-1,846 Reduced 2.64%
68,154 $0
Q3 2017

Nov 14, 2017

BUY
$17.65 - $18.99 $1.24 Million - $1.33 Million
70,000
70,000 $1.33 Billion

Others Institutions Holding DCPH

About Deciphera Pharmaceuticals, Inc.


  • Ticker DCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,822,100
  • Description
  • Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...
More about DCPH
Track This Portfolio

Track Pura Vida Investments, LLC Portfolio

Follow Pura Vida Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pura Vida Investments, LLC with notifications on news.